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The pathogenicity of Stenotrophomonas maltophilia is regulated in part by its quorum
sensing (QS) system. The main QS signaling molecule in S. maltophilia is known as
diffusible signal factor (DSF), and the rpf gene cluster is responsible for its synthesis
and perception. Two cluster variants have been previously described, rpf-1 and rpf-2,
which differ basically in the conditions under which DSF is produced. Here, correlations
between the rpf variant and antibiotic susceptibility, LPS electrophoretic profiles and
virulence-related phenotypes were evaluated for a collection of 78 geographically and
genetically diverse clinical strains of S. maltophilia. In general there were associations
between previously established genogroups and the genetic variant of the rpf cluster.
However, only few genotype-phenotype correlations could be observed. Resistance to
the β-lactam antibiotics ceftazidime and ticarcillin was associated with strains carrying
the rpf-1 variant, whereas strains of variant rpf-2, particularly those of genogroup C,
showed higher resistance levels to colistin. Strains of variant rpf-2 were also significantly
more virulent to Galleria mellonella larvae than those of rpf-1, most likely due to an
increased ability of rpf-2 strains to form biofilms. A comparative genomic analysis
revealed the presence of proteins unique to individual genogroups. In particular, the
strains of genogroup C share an operon that encodes for a new virulence determinant
in S. maltophilia related to the synthesis of an alternative Flp/Tad pilus. Overall, this
study establishes a link between the DSF-based QS system and the virulence and
resistance phenotypes in this species, and identifies potential high-risk clones circulating
in European hospitals.
Keywords: quorum sensing (QS), diffusible signal factor (DSF), MLST (multilocus sequence typing), rpf cluster,
biofilm, antibiotic resistance
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INTRODUCTION
Stenotrophomonas maltophilia are metabolically and genetically
diverse Gram-negative bacilli belonging to the γ-proteobacteria
class that inhabit a wide range of environmental niches, mainly
in association with plant rhizospheres (Ryan et al., 2009; Brooke,
2012). Although S. maltophilia are thought to be low-grade
pathogens and a rather uncommon cause of bacterial disease
in humans, they are increasingly recognized as significant
opportunistic pathogens in healthcare settings worldwide, being
one of the ten most common organisms found in respiratory
tissue samples taken from intensive care unit (ICU) patients
in Europe (Zuschneid et al., 2007; Gherardi et al., 2015).
Several nosocomial outbreaks of S. maltophilia infection and/or
colonization have been reported (Denton and Kerr, 1998),
and the global prevalence and incidence of these bacteria
as human pathogens have increased significantly during the
last decade (Chang et al., 2015; Nayyar et al., 2017; Rutter
et al., 2017), particularly in cystic fibrosis patients (Hatziagorou
et al., 2019). The most common clinical manifestations of
S. maltophilia infections include pneumonia, bacteremia, wound
or urinary-tract infections (Looney et al., 2009; Gales et al.,
2019), with crude mortality rates ranging from 14 to 69% in
patients with bacteremia, being highest among patients receiving
inappropriate initial antimicrobial therapy (Paez and Costa,
2008; Falagas et al., 2009; Kim et al., 2019). Most important,
S. maltophilia show low susceptibility to many antibiotics,
including those commonly used to treat infections by Gram-
negative opportunistic pathogens (Sánchez, 2015). Not only
have they a variety of intrinsic resistance mechanisms affecting
almost all antibiotic classes but they are also able to acquire
new resistances via horizontal gene transfer and mutations. The
phenomenon of heteroresistance has also been described in
S. maltophilia as a mechanism to withstand antibiotic treatment
(Martínez-Servat et al., 2018). For these reasons, this species
has been classified as one of the leading multidrug resistant
(MDR) organisms in hospital settings (Brooke, 2014) and has
now been included in the global priority list of the top 10 resistant
microorganisms (TOTEM) isolated in ICUs (Rello et al., 2019).
The pathogenesis of S. maltophilia infections involves several
virulence factors, including extracellular enzymes, bacterial
motility and biofilm formation (Trifonova and Strateva, 2019).
The ability to grow in matrix-enclosed biofilms is an important
virulence-related trait of pathogenic bacteria. Among other
functions, biofilms facilitate the development of bacterial
persistence within the host and increase resistance against the
host immune response (González et al., 2018) and antimicrobials
(Stewart, 2015), including the last-resort antibiotic colistin
(Mulcahy et al., 2008; Kim et al., 2015; Chua et al., 2016).
Thus, biofilm formation is regarded as a form of phenotypic
resistance (Olivares et al., 2013). S. maltophilia forms biofilms on
a wide range of biotic and abiotic surfaces, such as indwelling
medical devices (Di Bonaventura et al., 2007). Still, very little
is known about the genetic mechanisms that control biofilm
formation or virulence in these bacteria, and it is not clear
whether there is an intrinsic difference in biofilm formation
among genomically diverse environmental and clinical isolates
(Pompilio et al., 2011). S. maltophilia produces a wide range
of extracellular enzymes, including lipases, proteases, chitinases,
esterases, DNases, and RNases, contributing to its colonization
and virulence in different organisms (Ryan et al., 2009;
Trifonova and Strateva, 2019). Furthermore, it is well known
that S. maltophilia synthesizes diverse O-specific polysaccharide
structures that constitute immunodominant antigens of the
lipopolysaccharide (LPS) molecule and may contribute to the
pathogenicity of the bacterium (Waters et al., 2007; Knirel,
2011). A diffusible signal factor (DSF)-mediated quorum sensing
(QS) system, encoded by the rpf gene cluster, coordinates the
regulation of a number of phenotypes in S. maltophilia, such
as biofilm formation, secretion of proteases, virulence, and
tolerance to a range of antibiotics (Fouhy et al., 2007; Ryan
et al., 2009; Trifonova and Strateva, 2019). Two genetic variants
of the rpf gene cluster (rpf -1 and rpf -2) divide the strains into
two phenotypically and genotypically distinct subpopulations
(Huedo et al., 2014). Only rpf -1 strains produce detectable DSF,
which correlates with their ability to control biofilm formation,
motility and virulence (Huedo et al., 2014, 2015). However,
no clear link between the presence of a specific rpf variant
and the isolation source of the strains has been found so far
(Lira et al., 2017).
An additional important trait of S. maltophilia strains is
their high genetic diversity (Gherardi et al., 2015) that facilitates
adaptation to changing environmental conditions. Numerous
genotypic studies of both clinical and environmental strains
have revealed considerable variability among S. maltophilia
isolates (Nicoletti et al., 2011; Pompilio et al., 2011, 2016;
Ochoa-Sánchez and Vinuesa, 2017; Patil et al., 2018; Rizek
et al., 2018; Steinmann et al., 2018; Bostanghadiri et al., 2019;
Mojica et al., 2019). Due to these large genetic divergences,
and because previously proposed species are recognized to be
closely related to S. maltophilia, it is increasingly accepted
to present it as the S. maltophilia complex (Svensson-Stadler
et al., 2012; Patil et al., 2018; Vinuesa et al., 2018). PCR-
based multilocus sequence typing (MLST) and whole-genome
sequencing (WGS) have clearly shown the existence of several
genomic or phylogenetic groups in the S. maltophilia complex,
and have helped to clarify the taxonomic status of the species
(Hauben et al., 1999; Kaiser et al., 2009; Ochoa-Sánchez and
Vinuesa, 2017; Steinmann et al., 2018; Gröschel et al., 2020;
Mercier-Darty et al., 2020). Even strains isolated from the same
patient (Pompilio et al., 2016; Chung et al., 2017) or patients
within the same hospital (Valdezate et al., 2004) can belong to
distant phylogenetic groups with different phenotypes, probably
due to the emergence of adaptive mutations as a result of selective
pressure in the clinical environment or inside the host. In
addition to interstrain variability, some isolates show cell-to-cell
variation within a clonal population as a mechanism to survive
environmental fluctuations (Abda et al., 2015). The complex
genotypic and phenotypic heterogeneity between and within
S. maltophilia isolates hampers not only the effectiveness of
antimicrobial therapies but also investigations into the virulence
and resistance determinants of this species.
To deepen the knowledge and understanding of the resistance
and virulence phenotypes displayed by S. maltophilia, in a way
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that is consistent with this high-diversity context, we have studied
a panel of genetically diverse clinical S. maltophilia isolates with
focus on the two genetic variants of the DSF-mediated QS system.
Genetic characterization was performed using MLST and rpf
typing, together with the analysis of shared and unique proteins.
Phenotypic analyses included the determination of antibiotic
resistance profiles, biofilm formation, protease secretion, cell
motility and LPS banding patterns. Moreover, the virulence
of the isolates was assessed using two different non-vertebrate
model hosts. To our knowledge, a systematic analysis of the
population structure based on the two genetic variants of the
DSF-mediated QS system and its relationship with the resistance
and virulence phenoptypes of clinical S. maltophilia strains has
not yet been carried out.
MATERIALS AND METHODS
Bacterial Isolates and Growth Conditions
The strain collection used in this study consisted of 78 clinical
S. maltophilia isolates (Huedo et al., 2014) collected from point
prevalence studies in ICUs of geographically distant European
hospitals. The strain panel included isolates from sputum, blood
and swabs from surgical wound, oropharynx, perineum, vascular
ulcer, decubitus ulcer, or a bronchoaspirate (Supplementary
Table S1). All clinical strains were isolated from different patients,
except for five patients with two isolates each (Supplementary
Table S1). Three strains of S. maltophilia, namely K279a, D457,
and ATCC13637, were included as references. ATCC13637 was
purchased from the American Type Culture Collection. Unless
otherwise stated, cultures were routinely grown at 37◦C in LB
broth (10 g/L tryptone, 5 g/L yeast extract and 10 g/L NaCl)
on a rotary shaker at 200 rpm. The species of all isolates was
confirmed by matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) mass spectrometry (data not shown).
Genome Sequences and Comparative
Genomics
Annotated genome sequences of the unique isolates studied
here were generated in the study by Gröschel et al. (2020)
and are available from NCBI repository under the accession
numbers RASX00000000-RAVB00000000. Genome sequences
from S. maltophilia strains K279a, D457, and ATCC13637 were
obtained from the NCBI genome database1. The encoded protein
sequences were extracted from the genomes and compared
to identify core and exclusive proteins. Orthologous protein
sequences of the selected S. maltophilia strains were assessed by
complete reciprocal best hit using UCSC blat (Kent, 2002) as
comparison tool and accepting hits with a complete graph as
previously reported (Callister et al., 2008) or the largest clique.
This algorithm clusters the gene-derived proteins into core (hard
and soft) and accessory proteins. Hard core proteins are those
found in all genomes, while soft core proteins are found in
95–99% of genomes. Blastp2 and the HMM search program
1https://www.ncbi.nlm.nih.gov/genome/
2https://blast.ncbi.nlm.nih.gov/Blast.cgi
jackhmmer (Johnson et al., 2010) were used to identify homologs
of the protein sequences using several databases. Prediction
of operons was done using the online software and database
OperonDB (Pertea et al., 2009).
Genotypic Characterization and
Phylogenetic Analysis
Genotypic characterization was basically performed on the basis
of the MLST scheme for S. maltophilia (Kaiser et al., 2009).
In addition, determination of the rpf variant was included
in the genotyping as previously described (Huedo et al.,
2014). The detailed MLST procedure was obtained from the
S. maltophilia MLST database3. The allele numbers for each
locus and the sequence type (ST) were determined online at
the S. maltophilia MLST database. A combination of the allelic
sequences of the seven genes yielded the allelic profile for
each isolate. Concatenated sequences of the seven housekeeping
genes for each strain were aligned, and a phylogenetic tree
was constructed using MEGA version 7.0.21 (Kumar et al.,
2016) based on the neighbor-joining algorithm (Tamura–Nei
model). Phylogenetic trees were visualized and annotated using
the interactive web platform iTOL v3 (Letunic and Bork,
2016). To divide strains into clonal groups according to their
MLST allelic profiles and to infer the population structure,
BURST analysis (Feil et al., 2004) was used on the basis of
five shared loci.
Analysis of Antimicrobial Susceptibility
The minimum inhibitory concentrations (MICs) of antibiotics
were determined using Etest strips following the manufacturer’s
instructions (bioMérieux, Madrid, Spain). Briefly, a 0.5-
McFarland suspension was used to grow a confluent bacterial
lawn on Mueller–Hinton (MH) agar plates (bioMérieux). Seven
antibiotics with proven in vitro activity against S. maltophilia
(Falagas et al., 2008; Wang et al., 2014; Chang et al., 2015) were
used: ceftazidime, minocycline, levofloxacin, trimethoprim-
sulfamethoxazole, amikacin, ticarcillin-clavulanate, and colistin.
The MIC values were determined according to the Etest reading
guide after 18 h of incubation at 37◦C. The susceptibility test
results were interpreted according to clinical susceptibility
and resistance breakpoints (S) suggested by the Clinical and
Laboratory Standards Institute (CLSI) (CLSI, 2019). For
S. maltophilia, clinical breakpoints are now available for
trimethoprim-sulfamethoxazole (S ≤ 2 µg/mL), ticarcillin-
clavulanate (S ≤ 16 µg/mL), ceftazidime (S ≤ 8 µg/mL),
minocycline (S ≤ 4 µg/mL), and levofloxacin (S ≤ 2 µg/mL).
For amikacin and colistin, CLSI breakpoints for Pseudomonas
aeruginosa were used with susceptibility cutoffs of 16 and
2 µg/mL, respectively. Isolates with intermediate antibiogram
results were considered resistant (non-susceptible). MDR was
defined as non-susceptibility to at least one agent in three or
more antimicrobial categories (Magiorakos et al., 2012). The
MIC50 and MIC90 values represent the MIC value at which
≥50 and ≥90% of the strains within a test population are
inhibited, respectively.
3http://pubmlst.org/smaltophilia/
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In addition to the Etest method, colistin MICs were
determined by the broth microdilution (BMD) method in cation-
adjusted MH broth (CAMHB) in accordance with CLSI and
the European Committee on Antibiotic Susceptibility Testing
(EUCAST) joint recommendations (CLSI, 2019; EUCAST, 2019).
Briefly, MICs were determined in sterile 96-well plates by two-
fold serial dilutions of colistin sulfate (Apollo Scientific Ltd.,
Batch AS405305) in 100 µL of CAMHB. Bacteria were first grown
overnight in CAMHB using CLSI-recommended incubation
conditions. After that, 100 µL of the bacterial suspensions with
a final optical density at 550 nm (OD550) of 0.05 were added
to the wells containing the antibiotic dilutions, and the MIC
plates were read after 18 h of incubation at 37◦C. The MIC was
defined as the lowest antibiotic concentration that inhibited 80%
of growth (based on OD measurements) in comparison to the
control (CLSI, 2015).
SDS–PAGE and Immunoblotting of
Lipopolysaccharides
For identification of identical ladder-like LPS patterns, LPS
preparations from proteinase K-digested whole-cell lysates of
S. maltophilia isolates were separated on 12% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS–PAGE) gels
and stained with silver nitrate according to the method
of Hitchcock and Brown (1983). The lysates were prepared
from the biomass of overnight cultures grown on agar
plates. For immunoblots, a rabbit polyclonal antibody against
heat-inactivated S. maltophilia K279a cells was used. In
order to detect serological cross-reactivity between O-specific
polysaccharides, the antiserum was adsorbed with heat-killed
cells of a K279a 1rmlBACD mutant as previously described
(Steinmann et al., 2018). The LPS samples were electrotransferred
from SDS–PAGE gels onto polyvinylidene difluoride (PVDF)
membranes (Millipore, Merck, Darmstadt, Germany), followed
by incubation of the blots with adsorbed anti-K279a antibody.
The immunoblots were then treated with alkaline phosphatase-
conjugated AffiniPure goat anti-rabbit immunoglobulin (Ig)G
(H + L) (Dianova, Hamburg, Germany) and developed in
the presence of nitroblue tetrazolium and 5-bromo-4-chloro-3-
indolylphosphate substrate (Promega).
Production of Extracellular Protease
Extracellular proteolytic activity was assessed by means of casein
hydrolysis on LB agar supplemented with 1% (w/v) skimmed
milk. The bacterial suspensions (5 µL each with an OD550 of
0.5) were spotted onto the agar, and the plates were incubated
at 30◦C for 24 h. Proteolytic capacity was evaluated by measuring
the diameter of the translucent halos.
Twitching Motility
Twitching was assessed using subagar stab inoculations (stab
assay) from fresh overnight LB agar plates as previously described
(Rashid and Kornberg, 2000). To prepare twitching plates, LB
medium containing 1% (w/v) Noble agar (DifcoTM) was used.
After incubation at 30◦C for 24 h, the agar was removed from
the plates, and the twitching zones were visualized by staining
with 1% crystal violet (w/v) to measure their diameters. All
experiments were conducted in triplicate.
Biofilm Formation Assays
To determine biofilm formation, overnight cultures of each
isolate were grown aerobically (200 rpm) in LB at 30◦C, followed
by dilution of the cultures into fresh LB to an OD550 of 0.1.
Sterile untreated 96-well microtiter plates (BrandTech 781662)
were inoculated with 200 µL of the bacterial suspensions and
incubated at 30◦C for 24 h. Prior to biofilm quantification, cell
growth was estimated in each well by measuring the optical
density at 620 nm (OD620) using a microplate reader (Multilabel
Plater Reader VICTOR3). Quantification of the amount of
biofilm was performed by crystal violet (CV) staining as described
previously (Huedo et al., 2014). Briefly, wells containing adhered
cells were washed three times with water, fixed at 60◦C for 1 h
and stained for 15 min with 200 µL of a 0.1% CV solution.
The stained biofilms were rinsed with distilled water, allowed
to dry at 37◦C for 30 min and then extracted with 200 µL of
95% ethanol. The amount of biofilm was quantified by measuring
the OD550 of dissolved CV using a microplate reader. Biofilm
formation (OD550 of CV) was normalized to cell growth (OD620)
and reported as relative biofilm formation. For this quantitative
assay, we have used six to eight replicate wells for each isolate.
Based on the ratio (OD550 of CV)/(OD620 of cell growth), the
isolates were grouped into three categories to classify their ability
to form biofilm: weak (0 to 0.85), moderate (0.85 to 1.5), or strong
(>1.5) biofilm formers (Zhuo et al., 2014).
Virulence in Caenorhabditis elegans
Determination of the virulence of S. maltophilia strains in the
C. elegans CF512 infection model was based on the “slow killing”
method (Tan et al., 1999). C. elegans CF512 [fer-15(b26)II; fem-
1(hc17)IV], a strain showing temperature-dependent sterility,
was provided by the Caenorhabditis Genetics Center (CGC) and
routinely maintained on NGM plates (1.7% agar, 50 mM NaCl,
0.25% peptone, 1 mM CaCl2, 5 µg/mL cholesterol, 25 mM
KH2PO4, 1 mM MgSO4) seeded with Escherichia coli OP50
(provided by CGC) at 16◦C. Bacterial strains were grown in Brain
Heart Infusion (BHI) broth (BD Difco Bacto) overnight at 37◦C,
and 100 µL of each culture was spread onto a 5.5-cm-diameter
NGM agar plate and incubated at 37◦C for 24 h. Before usage,
plates were cooled down to room temperature, and 15–20 adult
hermaphrodite CF512 worms were placed onto plates seeded
with the bacterium of interest. Plates were incubated at 25◦C
(at which worms are sterile) and scored for live worms every
24 h. E. coli OP50 was used as a negative control. A worm was
considered dead when it no longer responded to touch. Three
replicates per strain were prepared.
Virulence in Galleria mellonella
Larvae of Galleria mellonella were obtained from our own
hatchery, which was established in collaboration with Professor
Fernando García del Pino from the Zoology Department at
the Universitat Autònoma de Barcelona. To prepare bacterial
inocula, S. maltophilia isolates were grown overnight at 37◦C in
10 mL of BHI in a rotary shaker at 200 rpm. Then, cells were
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sedimented by centrifugation, washed in PBS and adjusted to
contain approximately 5 × 105 CFU in a single dose of 5 µl.
Bacterial burden of the doses was confirmed by plating on BHI
medium. This inoculum size was selected based on previous
studies (Betts et al., 2014; García et al., 2015) that have determined
the optimal dose of S. maltophilia required to kill G. mellonella
over a 24–96 h period. Ten larvae per group were infected
through the left proleg using a 50-µl Hamilton R© MicroliterTM
syringe with the aforementioned inoculum and incubated in the
dark at 30◦C in empty petri dishes. Mortality was determined
every 24 h. Larvae were considered dead when they no longer
responded to touch, which correlates with total melanization
(black colored larvae).
Statistical Analysis
Statistical comparisons between groups were performed using
Welch’s t-test, i.e., assuming non-equal variance. The associations
between two categorical phenotype and genotype variables were
investigated using the z-test or Fisher’s exact test as appropriate
(Fisher’s exact test works better with small sample sizes). The
odds ratio (OR) with a corresponding 95% confidence interval
(95% CI) for each variable was calculated. In all cases a
p-value < 0.05 was considered statistically significant, and all tests
were two-tailed. Data were analyzed using SPSS 15.0 for Windows
(SPSS Inc., Chicago, IL, United States) or GraphPad Prism 5
(GraphPad Software, San Diego, CA, United States). For infection
experiments, the time at which 50% of animals were scored as
dead (LT50), was calculated using a non-linear regression based
on the Hill equation (GraphPad Prism 5).
RESULTS
Genetic Diversity of the S. maltophilia
Strains
To evaluate the genetic diversity and possible relations between
the S. maltophilia isolates involved in this study, their MLST
profiles were first analyzed. The 78 strains, isolated from patients
of different European countries, mapped to 37 STs (Figure 1
and Supplementary Table S1). At the date of submission to
the S. maltophilia MLST database, 30 of these STs were new
and designated ST-76 to ST-81 and ST-120 to ST-143. Fifteen
isolates (19.2%) belonged to seven previously described STs,
whereas 63 (80.8%) belonged to the 30 novel STs, corroborating
previous reports on the genotypic heterogeneity of S. maltophilia.
Although no predominant clonal group was identified by BURST
analysis, the three most frequent MLST genotypes were ST-77
(8 isolates), ST-132 (8 isolates), and ST-133 (7 isolates). The
remaining STs occurred each with a frequency lower than 5.0%.
When the entire S. maltophilia MLST database (522 isolates,
367 STs) was analyzed with the BURST algorithm, some of our
isolates were part of discrete clonal groups, sharing six (clonal
complexes, the most exclusive group definition) to five identical
alleles (Supplementary Figure S1). For instance, four strains
isolated from three different countries could be grouped into
one of the few clonal groups (ST-8) detected so far in the
global population of S. maltophilia (Supplementary Table S1 and
FIGURE 1 | Correlation between genotypes and antibiotic resistance profiles.
Neighbor-joining tree based on the concatenated data for all seven MLST loci
of the 61 “unique” S. maltophilia strains from this study. The ST of each isolate
is indicated (NA means not assigned). Previously defined genomic groups and
rpf variants are also indicated. Data for strain D457 was deduced from its
whole genome sequence (NCBI Reference Sequence: NC_017671.1). The
antibiotic resistance profiles are displayed as spheres of different sizes in
consecutive columns outside the tree. Data are presented as log2 fold
increase in resistance with respect to the clinical breakpoint for each antibiotic
(abbreviations as in Table 1). Highest values in the dataset have the largest
size, and all others are scaled down proportionally. Groups of LPS profiles are
also indicated (ND means undetermined). Presence of a K279a-like O-antigen
is indicated with black triangles.
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Supplementary Figure S1). Likewise, our predominant ST (ST-
77) comprises strains from different European countries and is
part of a genetically related group of the clonal complex ST-103
(Supplementary Figure S1). In addition to MLST, rpf genotyping
(Huedo et al., 2014) revealed that the rpf -1 variant was present in
a total of 47 strains (60%), while rpf -2 was identified in 31 strains
(40%) (Supplementary Table S1).
Among the 78 strains studied here, five pairs of isolates
were confirmed to be epidemiologically linked. They were either
cultured from two sources of the same patient on the same day
(four pairs) or originated from samples taken from the same
patient at different dates (pair OS91 and OS87) (Supplementary
Table S1). In most cases, the paired isolates share the same
ST, but isolates PU101 and PU102 are genetically distinct, with
only three alleles in common. Also, based on the MLST typing
and data from the source of isolation, among the 35 strains
collected from Germany, and coming from a single hospital,
there seems to be genetically related groups (Supplementary
Table S1). In order to avoid interference of clonal strains with
correlation tests, those isolates displaying identical MLST type
and isolation data (i.e., same source, patient, and date) were
considered as the same clone, so that only one representative
isolate was selected for further investigations (Supplementary
Table S1, highlighted in bold). However, those clonal strains
that showed different antibiotic susceptibility profiles (see below)
were not excluded from further analyses. Thus, the analysis of
correlations between the phenotypic and genotypic parameters
studied here was performed on 58 isolates. In addition, we have
included the strains K279a, D457, and ATCC13637 as references
in all experiments, yielding a total of 61 “unique strains” (36 rpf -1
and 25 rpf -2).
Classification of S. maltophilia Isolates
Into Genomic Groups
For cluster analysis, taxonomic status verification and assignment
of the S. maltophilia isolates to genomic groups, phylogenetic
analyses were carried out based primarily on concatenation of
the seven MLST genes (Figure 1 and Supplementary Figure S2).
A neighbor-joining tree of the 522 isolates in the MLST database
(Supplementary Figure S2) allowed us to cluster all these strains
according to the 20 genogroups (#1 to #10 and A to J) as
previously established by Hauben et al. (1999), Kaiser et al.
(2009), and Mercier-Darty et al. (2020). This phylogenetic
analysis showed a lack of clustering by isolation source or
geographical origin (Supplementary Figure S2), which stresses
again the heterogeneity of S. maltophilia isolates, in this case
at a worldwide level. Even though most of the strains in the
MLST database were of clinical origin, it is noteworthy that
almost all environmental strains were clustered in groups #8,
#9, and #10. The 78 strains in our panel could be clustered into
12 genogroups (Supplementary Table S1), including the new
group G (4 strains) by Mercier-Darty et al. (2020). Therefore,
our strain collection provides a good representation of the
global diversity of S. maltophilia. Nineteen (31%) of the 61
unique isolates were clustered in genogroup #6, including the
clonal complex ST-8 (Figure 1). Genomic group #6 comprises
the so far largest number of strains in the MLST database
(Supplementary Figure S2) and includes the reference strain
ATCC13637 and the reference genome strain K279a. The other
genogroups with a significant number of isolates in our collection
were #2 (19%), #3 (13%) and C (15%), which is in agreement
with the frequency of isolates belonging to these groups in
the worldwide population. In agreement with previous studies
(Corlouer et al., 2017; Mercier-Darty et al., 2020), genogroup #2
represents the most genetically diverse group in our collection. As
proposed by Gröschel et al. (2020) and shown in Supplementary
Table S1, the strains could be further classified into the
monophyletic lineages named Sm1–Sm18 (termed S. maltophilia
sensu lato) or the more distantly related lineages Sgn1–Sgn4
according to Vinuesa et al. (2018). All our strains, except the
phylogenetically distant strain OU111 (genogroup A), belong to
the S. maltophilia sensu lato cluster. None of them clustered into
lineages in which there are isolates mislabeled as S. maltophilia
or with an unclear taxonomic status, for example the genomic
groups #8 and #10 (Ochoa-Sánchez and Vinuesa, 2017). In
this respect, our results therefore could provide support for
the multispecies concept to explain diversity among isolates of
S. maltophilia.
Interestingly, there were statistically significant associations
between the major MLST-based genomic groups and the rpf
variants. In the genomic group #6, most of the strains contained
the variant rpf -1 (P < 0.001), whereas the variant rpf -2 was
predominant in genogroups C (P < 0.001) and #3 (P < 0.05).
Identification of Core and Unique
Proteins Within S. maltophilia Strains
and Genogroups
In addition to the genotypic characterization, the genome-
derived protein sequences of 60 unique strains of S. maltophilia
were compared to identify core and exclusive proteins (assembled
genome sequence of PR59 could not be determined). According
to our ortholog identification method, the S. maltophilia strains
included in this comparison share a core genome of 2,585
proteins. If we consider the soft core genome (proteins present
in 95–99% of genomes), 349 additional proteins could be added
to this set of shared proteins. We also identified the number
of exclusive proteins shared by all members of each genogroup
(Figure 2A and Supplementary Table S2). The analysis showed
that the number of unique proteins to each genogroup varies
considerably from genogroup to genogroup. Genogroups #5, #7,
D and A clearly stand out having the highest number of unique
proteins; this is likely due to these groups being represented
by a single strain. It is worth mentioning that all members of
genogroup C share 17 unique proteins, 12 of which are part
of an operon that encodes a protein translocation system for
the assembly of Flp or Tad (tight adherence) pilus (Figure 2B).
Moreover, members of genogroup #4 share a unique operon for
exopolysaccharide synthesis, and isolates in genogroup G share
41 proteins including peptidases and a transcriptional regulator,
in addition to other unique enzymes and several hypothetical
proteins (Supplementary Table S2). On the other hand, the
comparative analysis did not identify proteins shared exclusively
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FIGURE 2 | Comparative genomics of S. maltophilia genomic groups. (A) Flower plot of unique proteins in each genogroup and size of the hard-core proteome. The
petals marked with diagonal lines represent the genomic groups where the strains are mainly of the rpf-2 variant. The identified unique proteins to each genogroup
are listed in Supplementary Table S2. (B) Linear map showing the Flp/Tad pilus-encoding gene cluster exclusive to all strains of genogroup C (rpf-2), based on
strain D457 (NCBI Reference Sequence: NC_017671.1) as the reference genome. The coding sequences (CDS) are numbered from 1 to 14 and the functions of the
encoded proteins are shown below the map. Two CDS (empty arrows) were not detected as unique by our algorithm because they have paralogs within each
genome.
by strains of the rpf -1 or rpf -2 variants. This result highlights
the genetic heterogeneity among clinical S. maltophilia isolates
and confirms, in addition to their distribution along genotypes,
that the origin of the two rpf variants in S. maltophilia can be
explained by horizontal gene transfer.
Diversity of S. maltophilia Isolates Based
on Their LPS Profiles
The enormous structural diversity of surface-exposed O-specific
polysaccharides of smooth-type LPS is assumed to result from
adaptive mechanisms that enable the bacteria to withstand
specific conditions in various environmental niches, which in
turn provides the possibility of using O-polysaccharides as an
epidemiological marker to discriminate between related and
unrelated strains within a given species (Rimler, 1990; Aucken
and Pitt, 1993; Santamaría et al., 1998). We therefore compared
the LPS profiles of our S. maltophilia isolates as an additional
marker to cluster the strains on the basis of identical LPS
patterns in SDS-PAGE, the ladder-like appearance of which is
caused by varying numbers of oligosaccharide repeating units
in the O-specific polysaccharide (Supplementary Figure S3). As
expected, we could observe significant heterogeneity of the LPS
banding patterns, whereby none of the isolates investigated here
synthesized rough-type LPS lacking the O-specific polysaccharide
(Supplementary Figure S3). This was also valid for the strains
B5565, H5726 and PU126, but unequivocal evidence for the
presence of smooth-type LPS could only be obtained using
increasing amounts of LPS in SDS-PAGE (Supplementary
Figure S3, inset). The three strains were therefore excluded from
further analysis of LPS profiles. Based on the electrophoretic
mobility of higher molecular mass LPS species, we assigned
76 strains to a total of 31 LPS groups, including 20
isolates with apparently unique LPS patterns (Supplementary
Table S1). There were at least two different LPS profiles in
each of the genogroups with more than one member, where
genogroups F and C with dominating LPS groups 21 and 15,
respectively, were the most homogeneous. In summary, apart
from some exceptions, we could uncover a good correlation
between the LPS profile and the ST of the isolates, which
was largely in accord with the phylogenetic tree shown in
Figure 2. Furthermore, the LPS samples were screened with
a polyclonal antiserum raised against the O-antigen of strain
K279a, which has been recently proposed to share similar
characteristics with the S. maltophilia O8-antigen of a branched
tetra-saccharide with three rhamnopyranosyl residues in the
main chain and 3-O-methylxylose as substituent (Steinmann
et al., 2018) (Supplementary Figure S3). Our immunoblot
analyses indicated serological cross-reactivity of the antiserum
with the O-antigens of all strains of LPS profile group 2
(including S. maltophilia K279a), which accounts for 14.5% of
all examined isolates. Interestingly, the LPS of all strains of
genogroup #4 (3.9%) cross-reacted as well with the antibody,
suggesting that these isolates, despite showing different LPS
banding patterns, expressed an O-specific polysaccharide either
structurally similar or even identical to that of the reference
strain K279a. Of note, each of the ten separate groups
comprising two to six clonal strains did not only display
an identical MLST type, but could also be assigned to one
and the same LPS group, which supported the conclusion of
epidemiologically linked strains that were isolated at the same
hospital in Germany (Supplementary Table S1). All strains
that reacted with the O-specific K279a antiserum carried the
rpf -1 cluster, except for strain OC323 (genetically close to
K279a) which encoded the rpf -2 variant (Figure 1). This could
be in fact another indication that the two rpf variants in
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S. maltophilia were acquired by horizontal gene transfer as
previously suggested (Huedo et al., 2015), at least for strain
OC323 that may have received the rpf -2 cluster more recently
by recombination events.
Correlation Between Antibiotic
Resistance Phenotypes and Genotypes
The antibiotic resistance pattern of our isolates was evaluated
with the β-lactam antibiotics ceftazidime and ticarcillin-
clavulanate, and the non-β-lactam antimicrobials amikacin,
trimethoprim-sulfamethoxazole, levofloxacin, minocycline and
colistin (MIC values in Supplementary Table S1). The MIC
values of all antimicrobials were determined by the Etest, with
the exception of colistin, which was additionally tested using
the BMD method (see section “Materials and Methods”). All
strains were susceptible to minocycline, and only 6.5 and 19.7%
of the unique strains were non-susceptible to trimethoprim-
sulfamethoxazole and levofloxacin, respectively. Conversely, high
resistance rates were detected against the antibiotics amikacin
(54.1%), ticarcillin-clavulanate (62.3%), and ceftazidime (62.3%),
all of them with MIC values reaching >256 µg/mL (Table 1).
For colistin susceptibility testing, as expected (Moskowitz
et al., 2010), the results of the BMD and Etest methods
were significantly different. For our strain collection, the Etest
resulted in a colistin MIC50 value of 2 µg/mL corresponding
to susceptible strains (susceptibility breakpoint ≤ 2 µg/mL),
whereas the BMD method yielded a colistin MIC50 value above
the susceptibility breakpoint (>2 µg/mL) (Table 1). Moreover,
while the colistin MIC90 value determined by both methods
was consistent with a resistant phenotype, it was eightfold lower
by the Etest than by the BMD method. This is due to the
phenomenon of heteroresistance to colistin displayed by most of
the S. maltophilia isolates (Martínez-Servat et al., 2018). Finally,
taking the recommended BMD method as a reference, 67.3% of
the strains could be considered as non-susceptible to colistin.
To further characterize the resistance patterns, the criteria
suggested by Magiorakos et al. (2012) for related non-
fermenting Gram-negative bacteria were applied. Among the
61 unique isolates, 37 (60.7%) were found to be MDR strains,
whereas 24 (39.3%) were not. On the other hand, 22 different
antibiotic resistance profiles were observed among the 61 strains
(Supplementary Table S1 and Figure 1), the most common
being those that combine resistance to ceftazidime, amikacin,
ticarcillin-clavulanate, and colistin. Notably, in three out of five
strain pairs isolated from the same patient, the members of the
same pair showed different resistance profiles (Supplementary
Table S1). The two genetically different strains isolated from
the oropharinx and the perineum of the same patient, PU101
and PU102, displayed the same resistance profile. These strains
were also assigned to different LPS groups. Strain OL11 was the
most resistant isolate in our panel (six out of seven antibiotics).
It had been isolated with PL12 from different anatomical sites
of the same patient. The two strains are genetically identical,
possess the same LPS profile (Supplementary Table S1) and
are resistant to almost all antibiotics, except that PL12 showed
susceptibility to colistin. On the other end, strains OU152,
OU343, and OL16, all belonging to different and distant
genogroups (Figure 1), were susceptible to all antibiotics tested
(Supplementary Table S1). Overall, no significant correlations
were observed between the resistance profiles (antibiotic
resistance combinations) and the MLST genotypes. However,
statistically significant associations could be observed between
specific genomic groups and the susceptibility of the isolates
to certain antibiotics (Supplementary Table S3). For instance,
almost all strains of the genogroup #6 were susceptible to
ticarcillin-clavulanate, whereas strains of genogroups #2 and F
were mostly susceptible to colistin but ceftazidime resistant.
The genetically related strains of genogroups #2 and F showed
similar resistance profiles and were therefore considered as a
whole in association studies. In addition, we found high-level
resistance to levofloxacin in all strains of the new genogroup
G. Almost all strains of the genogroup C were susceptible
to the β-lactams ceftazidime and ticarcillin-clavulanate, but
were quantitatively more resistant to colistin (Supplementary
Table S3 and Figure 1). Interestingly, the variant of the rpf
cluster showed some correlation with the resistance profile of the
isolates. Most of the rpf -1 strains turned out to be resistant to
ceftazidime (P = 0.014), and, from a quantitative point of view,
the rpf -2 resistant strains inclined toward higher MIC values
for colistin compared to the rpf -1 variant, although without
statistical significance (Figure 3A). This analysis also showed
higher resistance levels to ceftazidime and ticarcillin-clavulanate
among resistant strains of the rpf -1 variant.
Correlation Between Genotypes and
Virulence-Related Phenotypes
Virulence-associated phenotypes, including biofilm formation,
production of extracellular enzymes and motility, were finally
assayed for our strain collection. All isolates were protease and
biofilm producers (Supplementary Figure S4). However, the
amount of biofilm formed in vitro varied considerably among
S. maltophilia isolates. The rpf -2 strain OU110 exhibited the
highest biofilm-forming ability. Most of the isolates (44.3%,
27/61) produced moderate biofilms; with a mean of 1.14 and
standard deviation of ±0.17 (see “Materials and Methods”
section for measurement and classification of biofilms). Strong
biofilm formation capacity (mean: 1.95, SD:±0.43) was observed
in 24.6% (15/61) of the isolates, whereas the remaining
19 strains (31.1%) showed weak biofilm formation capacity
(mean: 0.38, SD: ±0.24). With respect to genotypes, we found
statistically significant associations (P < 0.005) between the
isolates of genomic group C and their ability to form biofilm
(Supplementary Table S4). On the contrary, 90.9% of strains of
genomic groups #6, F and #2 were moderate to weak biofilm
producers, though without significant associations. Once again,
despite variations in phenotypic traits, the biofilm-forming ability
of the strains could be related to the rpf variant. Quantitatively,
the biofilm formation capacity of rpf -2 strains (relative biofilm
mean 1.38) was significantly higher (P < 0.05) than that of
rpf -1 strains (relative biofilm mean 0.92) (Figure 3B). With
respect to the number of isolates, strains of variant rpf -1
are mostly moderate to weak biofilm formers (P < 0.001)
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TABLE 1 | In vitro activity (µg/mL) of seven antimicrobial agents against the 61 “unique” strains of S. maltophilia studied here.
Method Agent Class or sub-class MIC50a MIC90a Range % of susceptible isolatesb
Etest Ceftazidime (CAZ) Cephalosporins 16 >256 1–>256 37.7
Minocycline (MIN) Tetracyclines 0.25 0.5 0.032–2 100
Levofloxacin (LEV) Fluoroquinolones 0.5 16 0.125–>32 80.3
Trimethoprim-
sulfamethoxazole (SXT)
Folate pathway inhibitors 0.25 0.5 0.125–>32 93.5
Amikacin (AMK) Aminoglycosides 32 256 2–>256 45.9
Ticarcillin-clavulanate (TTC) Penicillins 64 >256 0.5–>256 37.7
Colistin (COL) Polymyxins 2 8 0.064–32 75.4
BMDc Colistin Polymyxins 8 64 <0.25–>256 32.7
aMIC90 and MIC50 values were defined as the lowest concentration of the antibiotic on a two-fold scale at which 90 and 50% of the isolates were inhibited, respectively.
bSusceptibility breakpoints for S. maltophilia established by the Clinical and Laboratory Standards Institute (CLSI, 2019). For amikacin and colistin, CLSI breakpoints for
P. aeruginosa were used. Intermediate and resistant strains were grouped together into a non-susceptible category. cBroth microdilution.
FIGURE 3 | Phenotypic resistance and virulence-related phenotypes within each rpf-variant subpopulation of S. maltophilia. (A) Box and whisker plots (range bars
indicate maximum and minimum values) showing log2-fold change increase from susceptibility cut-off for each antibiotic: CAZ, ceftazidime; LEV, levofloxacin; AMK,
amikacin; TTC, ticarcillin-clavulanate; COL, colistin. Only resistant isolates were included. (B) Profiles for virulence traits of isolates from different rpf-variant
subpopulations (*p < 0.05; unpaired t-test with Welch’s correction).
(Supplementary Table S5). On the other hand, there was no
statistically significant correlation of protease secretion and
twitching motility with the phylogenetic clustering, except for
strains belonging to genogroup C or those that are of the
rpf -1 variant, which are less casein exoprotease producers
(Supplementary Figure S4 and Supplementary Tables S4, S5).
The virulence capacity of the strains was investigated by
infecting both the nematode C. elegans and larvae of the insect
G. mellonella. The results were compared and correlated with
the assayed virulence-related phenotypes. The S. maltophilia
strains evaluated in this study were differentially virulent to
C. elegans in the slow killing assay, with no correlation
found with genomic groups (Supplementary Figure S4 and
Supplementary Table S4). The strains required 4–10 ten
days to kill 50% of the worms (mean LT50 = 6.9 days).
Complete killing by E. coli OP50, used as a negative control,
was achieved after 15 days. No significant correlation was
found between the assayed virulence-related phenotypes and
the virulence of the strains in the C. elegans model. The two
least virulent strains in this model, PC274 (LT50 = 10.5 days)
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and the type strain ATCC13637 (LT50 = 10.0 days), showed
low motility and biofilm formation capacity and produced
lower amounts of extracellular proteases. Nevertheless, the
most virulent strain EV5520 (LT50 = 3.8 days) displayed also
weak virulence-related phenotypes, indicating that virulence
factors other than those examined here contribute to the
infection process in the nematodes. In general the type
strain ATCC13637 showed obvious signs of attenuation in
all assays (Supplementary Figure S4), as previously reported
using a zebrafish infection model (Ferrer-Navarro et al., 2013),
most likely due to numerous in vitro passages since it was
isolated in 1960.
All S. maltophilia isolates were virulent to G. mellonella larvae
in killing assays. The selected inoculum size of 5 × 105 CFU
resulted in 20–60% death at 24 h post-inoculation with most
strains, while complete killing was observed after 96 h. Some
strains were considered to be highly virulent as they were
able to kill approximately 60% of the larvae after 24 h of
inoculation and reached 100% after 48 h. These highly virulent
strains belong to almost all genogroups and rpf variants.
Nevertheless, on average, rpf -2 strains were more virulent than
rpf -1 strains (P = 0.05) on the basis of LT50 values (Figure 3B).
The association results showed again no significant correlation
between virulence-related phenotypes and the capacity of the
strains to kill the larvae.
DISCUSSION
In recent years S. maltophilia has received considerable attention.
First, the frequency of MDR phenotypes found among isolates
is particularly high, as demonstrated by the panel studied here.
Second, S. maltophilia is capable of surviving in a wide variety of
environmental niches, partly due to its capacity to form biofilms
on diverse biotic and abiotic surfaces, including medical devices.
Finally, S. maltophilia is characterized by a high rate of genomic
re-arrangements and hypermutator activity, which allows rapid
adaptation to new niches (Berg and Martinez, 2015). With this
presentation card, it does not come as a surprise that, despite not
being a particularly pathogenic or virulent species, S. maltophilia
has found its way as an emerging nosocomial pathogen (Brooke,
2012; Adegoke et al., 2017).
Although 60.7% of the clinical strains investigated in this work
were MDR, most isolates were susceptible to trimethoprim-
sulphamethoxazole and all to minocycline. Monotherapy
with trimethoprim-sulfamethoxazole, fluoroquinolones or
tetracyclines such as tigecycline, minocycline, and doxycycline
remains the most effective antimicrobial treatment against this
organism (Chang et al., 2015; Hand et al., 2016). However,
resistance to levofloxacin was detected in almost one fifth of
the strains evaluated in this study. Even though trimethoprim-
sulphamethoxazole is indeed the first choice antibiotic against
S. maltophilia, resistance to this drug has been observed in
6.5% of the strains included in this work, as it has also been
reported in other studies (Valdezate et al., 2001). Minocycline
emerges as the best alternative to treat S. maltophilia, but more
studies are needed to introduce this antibiotic into clinical
practice (Hand et al., 2016). On the other hand, colistin is
usually the last resort antibiotic for treatment of infections
caused by MDR strains, despite its proven toxicity (Petrosillo
et al., 2008; Wood et al., 2010). In the present study, in
addition to a high proportion of colistin-resistant isolates,
we have shown that S. maltophilia was capable of developing
colistin-resistance heterogeneity, deduced from the observed
discrepancies between the two commonly used susceptibility
testing methods (Etest vs. BMD) (Lo-Ten-Foe et al., 2007).
This is in agreement with our previous, more detailed studies
on heteroresistance with four colistin resistant S. maltophilia
strains (Martínez-Servat et al., 2018). Based on the strain
characterization presented here, this phenotypic heterogeneity
seems to be widely spread among clinical isolates regardless of
their genotypes and resistance profiles. Due to the emergence
of resistances to almost all antibiotic classes and the observed
heteroresistance phenomenon, combination therapies and novel
agents may soon be needed to treat infections caused by MDR
S. maltophilia strains.
An important finding of this study is that resistance to some
antibiotics appears to be influenced by the rpf variant. For
instance, while the rpf -1 subpopulation displayed higher levels of
resistance to the β-lactam antibiotics ceftazidime and ticarcillin,
strains of the rpf -2 group showed higher resistance levels to
colistin (Figure 3A). The differential resistance profiles found
for the rpf -1 and rpf -2 subpopulations may be attributable
to inherent DSF production and its lack in rpf -1 and rpf -2
subpopulations, respectively (Huedo et al., 2014). While rpf -1
strains synthesize DSF under standard conditions activating
the QS, rpf -2 strains require detection of exogenous DSF to
trigger DSF production (Huedo et al., 2015). In this line, it
has been reported that DSF signals stimulate the production
and release of outer membrane vesicles (OMVs), which may
contain β-lactamases (Devos et al., 2015). Furthermore, some
antibiotic resistance mechanisms seem to be controlled by
DSF in the plant-growth-promoting model strain S. maltophilia
R551-3 (rpf -1), including the biosynthesis of β-lactamases and
multidrug efflux pumps (Alavi et al., 2013). On the other hand,
in time-kill curve experiments, S. maltophilia’s DSF seemed to
influence polymyxin tolerance in P. aeruginosa, with addition
of DSF leading to an enhanced tolerance to polymyxin B
and colistin (Ryan et al., 2008). We have recently shown
that naturally occurring DSF signals and synthetic derivatives
potentiate the activity of the polymyxin antibiotic colistin against
S. maltophilia and some members of the Burkholderia cepacia
complex (Huedo et al., 2019). Accumulation of DSF on the
surface may slightly increase the permeabilization of the bacterial
membrane due to its lipophilic nature, potentiating colistin
activity against rpf -1 strains. Worth mentioning, there appear
to be associations between MLST genotypes and antibiotic
resistance regardless of the rpf cluster variant. Strains of
genogroup C were mostly susceptible to ticarcillin-clavulanate
in addition to ceftazidime. Moreover, all strains of genogroups
#4 (rpf -1) and G (rpf -2) were resistant to levofloxacin, and
most strains of genogroups #2 and F (mostly rpf -1) were
susceptible to amikacin. A significant proportion of β-lactam-
resistant isolates arise in S. maltophilia through altered expression
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of β-lactamases (Sánchez, 2015) or amino acid substitutions
in efflux pumps (Blanco et al., 2019). Both intrinsic and
acquired resistance mechanisms are also involved in resistance
to aminoglycosides and quinolones in S. maltophilia, such
as expression of multidrug−resistant efflux pumps, presence
of antibiotic inactivating enzymes or mutations in the genes
coding for antibiotic targets (García-León et al., 2014; Sánchez,
2015). The comparative genomic analysis found no unique
proteins shared by members of a genomic group that would
be involved, in a straightforward, direct way, in antibiotic
resistance (Supplementary Table S2). Taken together, these
findings confirm that mutations, together with horizontal gene
transfer, affect the resistance patterns in S. maltophilia isolates
beyond genomic diversity.
In addition to antibiotic resistance, the genetic variant of the
DSF QS system has an impact on pathogenicity of S. maltophilia
as well, and many virulence determinants are involved in
this process. Biofilm formation is associated with an increase
in virulence of S. maltophilia. Although the biofilm forming
capacity varied considerably among the strains studied here,
consistent with previous observations from our group (Huedo
et al., 2014), we have shown that strains carrying the rpf -2
variant are stronger biofilm producers than strains carrying the
rpf -1 version (Figure 3B). In a previous study, we showed
that, although the protein variant RpfF-2 is functional in DSF
synthesis, its permanent repression by RpfC-2 results in the
absence of DSF production under the conditions tested. In
contrast, the rpf -1 subpopulation produces larger amounts of
DSF and, in that case, DSF seems to contribute to biofilm
dispersion (Huedo et al., 2014). Similar results were observed for
the closely related bacterium Xanthomonas campestris (encoding
a very close RpfF-1 variant), in which DSF also appears to
disperse biofilms (Dow et al., 2003). Likewise, in P. aeruginosa,
a related DSF signal, formerly termed cis-DA, displayed a strong
dispersion capacity of mature biofilms of a large number of
bacterial pathogens (Davies and Marques, 2009). Overall, it
seems likely that the absence of DSF production confers on
rpf -2 members a stronger ability to form biofilms, and this
may partially explain why these strains are more virulent in
larvae of G. mellonella. Pompilio et al. (2016) observed that
S. maltophilia biofilm formation is directly associated with
mortality rate in G. mellonella. In general, DSF signaling in
S. maltophilia regulates factors contributing to virulence, such
as motility, biofilm formation and colonization (Alavi et al.,
2013; An and Tang, 2018). However, no correlation could be
detected when comparing virulence and biofilm formation with
casein proteolitic activity or twitching motility, suggesting that
the latter attributes are not major virulence traits of S. maltophilia,
at least in the two infection models tested. On the other hand,
no significant association between antibiotic resistance and the
amount of biofilm formed could be observed. Thus, our results
are similar to those reported by Pompilio et al. (2016) but
diverge from those reported by Liaw et al. (2010), who concluded
that MDR isolates show higher levels of biofilm formation in
comparison to non-MDR strains.
In S. maltophilia, the high intra-specific genetic variability,
together with a low diversity of the known resistance and
virulence factors (Berg and Martinez, 2015) significantly
impedes the establishment of relationships with epidemiological
relevance. Although we could not uncover significant
correlations between all phylogenetic groups and virulence-
related phenotypes, we have identified groups of genetically
related strains that are scattered throughout European countries
and could represent high-risk clones. For instance, although
the number of strains tested is small, it can be observed that
genogroup C comprises stronger biofilm-forming strains that
are almost all resistant to the last-resort antibiotic colistin.
However, all these strains are susceptible to other antibiotics
tested herein and, thus; there remain good treatment options
against infections caused by them. Nevertheless, strains of
this group associated with human infections (Supplementary
Table S1) have also proven to be highly virulent in different
infection models (Ferrer-Navarro et al., 2013; Huedo et al.,
2014), and can quickly acquire a resistant phenotype (Alonso
and Martínez, 1997; Martínez-Servat et al., 2018). Interestingly,
all strains of group C seem to express an additional type
of the Flp/Tad pilus encoded by a unique cluster of genes
(operon SMD_0948-SMD_0960 in D457). This operon seems
to be different from the TadE-like pili gene cluster located at
Smlt2867-Smlt2875 in the K279a genome (Crossman et al.,
2008), although some components are similar. In strain D457,
the closest ortholog to the Flp/Tad pilus in K279a is the system
encoded by operon SMD_2505-SMD_2513. The Flp/Tad pilus
has been categorized as a subtype of the type II secretion
system (Tomich et al., 2007), and the encoding cluster is present
in a wide variety of bacterial species, for which it functions
as an important virulence factor. It is considered a target of
horizontal gene transfer and is essential for biofilm formation
(Tomich et al., 2007; Nykyri et al., 2013). To our knowledge,
it is the first time that this alternative structure has been found
encoded in the genome of strains of S. maltophilia, which
could contribute to the virulence of these strains. Besides,
the genogroup #6 includes the largest subgroup of our strain
collection. Of note, the predominance of clinical isolates in
genogroup #6 has also been shown by others, mostly in cystic
fibrosis patients (Kaiser et al., 2009; Vasileuskaya-Schulz et al.,
2011; Corlouer et al., 2017; Ochoa-Sánchez and Vinuesa, 2017;
Steinmann et al., 2018). Three of a total of four trimethoprim-
sulfamethoxazole resistant isolates of our collection belong to
genogroup #6, this antibiotic being a first-line therapeutic choice
in S. maltophilia infections.
Phylogenomic analyses linked with comparative
LPS profiling and O-serotyping have recently revealed
correlations between genomic classification of a number
of S. maltophilia isolates and electrophoretic banding
patterns of their LPS in silver-stained polyacrylamide gels
and immunoblots with an antibody raised against the
O-antigen of the reference strain S. maltophilia K279a
(Steinmann et al., 2018). The results obtained here confirm
the usefulness of LPS profile typing in combination with
immunoblotting as a supportive tool for identification of
epidemiologically related S. maltophilia strains. The LPS-
based approach was not only suited to supplement the
genotypic characterization of our diverse strain panel, but
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could also corroborate previous data on the high variability of
O-polysaccharide structures among S. maltophilia strains.
CONCLUSION
Overall, this study shows that the QS system plays a pivotal role
in pathogenicity and persistence in S. maltophilia. Furthermore,
since there are significant correlations between the rpf variant
and the phylogenetic groups of the isolates based on their MLST
profiles (Supplementary Table S4), this genotyping method
could be valid as an epidemiological tool. Genome sequencing
studies also revealed genes that are exclusive to certain groups
of isolates and could contribute to the observed phenotypes,
showing that other factors besides DSF synthesis contribute
to the virulence and resistance of S. maltophilia. More in-
depth genomic analysis (e.g., single nucleotide polymorphism
detection), together with phenotypic characterization of a larger
collection of representative clinical isolates of S. maltophilia,
will give a much deeper understanding of genetic diversity,
phylogeny, population structure and epidemiology of this
pathogen. For instance, this will allow the discovery of point
mutations involved in antibiotic resistance, for example, in clonal
strains isolated from the same patient. Altogether, this could
have significant implications in understanding the biology of
this species and, even more important, in the management of
S. maltophilia infections.
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